PharmaCielo Ltd. News Releases

PharmaCielo Announces Intention to Issue Interest Shares

Fri, 17 Apr 2026 07:30:00 -0400

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - April 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and food and medicinal grade cannabis extracts for the natural pharmaceuticals and consumer products market, PharmaCielo Colombia Holdings S.A.S., today announced that it intends to issue, subject...

PharmaCielo Announces the Issuance of Interest Shares

Tue, 17 Mar 2026 07:30:00 -0400

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that, as approved by the TSX Venture Exchange (the "TSXV"), it is issuing 12,153,937 common shares of...

PharmaCielo Announces 2025 Q3 Results, AGM Details

Mon, 02 Mar 2026 07:30:00 -0500

Achieves Positive Adjusted EBITDA All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 2, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced results of the quarter ended December 31, 2025.Summary Financials -...

PharmaCielo Announces Annual General Meeting and Intention to Issue Interest Shares

Tue, 17 Feb 2026 07:45:00 -0500

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - February 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and food and medicinal grade cannabis extracts for the natural pharmaceuticals and consumer products market, PharmaCielo Colombia Holdings S.A.S., today announced that it will hold its annual...

PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters

Tue, 30 Dec 2025 07:30:00 -0500

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 30, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced revocation of FFCTO and related corporate matters.Reinstatement to TradingEffective October 27, 2025,...

PharmaCielo Announces Issuance of Cease Trade Order

Wed, 06 Aug 2025 09:30:00 -0400

All amounts expressed in Canadian dollars unless otherwise notedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 6, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that the Ontario Securities Commission (the "OSC"), as its principal regulator, has issued a failure...

PharmaCielo Reports Q4 2024 Financial Results

Fri, 28 Feb 2025 07:45:00 -0500

PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million.Revenues and Gross Profit Margin Increased with More Diverse Customer Base.Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs.Financial Year-End is March 31. Audited Financial Statements will be for the Fifteen-Month Period from January 1, 2024, to March 31, 2025. Toronto, Ontario and...

PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing

Wed, 12 Feb 2025 07:45:00 -0500

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - February 12, 2025) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced issuance of shares for settlement of certain amounts owing. Settlement of DebtToday, the Company...

PharmaCielo Reports Q3 2024 Financial Results

Mon, 02 Dec 2024 07:45:00 -0500

PharmaCielo achieved 85% Year-Over-Year Sales Growth, Generating Year-to-Date Q3 Total Revenue of $2.4 MillionQ3 Gross Profit Turned Positive Reflecting More Diverse Customer BaseQ3 Cash Flow Improved and EBITDA Increased by $0.8 Million Reflecting Strong Sales Growth and Reduced CostsToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - December 2, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), a global cannabis products company and Colombia's premier...

PharmaCielo Announces Intention to Extend Expiry Date of Warrants

Tue, 05 Nov 2024 12:36:00 -0500

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 5, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced its intention to extend expiry date of 9,007,200 warrants. Warrant Extension PharmaCielo has applied to the...